| |
| |
|
| Insider
Information: |
Bell Leonard |
| Relationship: |
Director |
| City: |
Cheshire |
| State: |
CT |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
390,670 |
|
|
Indirect Shares
|
403,285 |
|
|
| Direct
Value |
$71,297,275 |
|
|
|
Indirect Value
|
$73,599,513 |
|
|
| Total
Shares |
793,955 |
|
|
| Total
Value |
$144,896,788 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Alexion Pharmaceuticals Inc |
ALXN |
Director |
2017-03-01 |
390,670 |
2017-01-09 |
403,285 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-09 |
4 |
OE |
$2.69 |
$382,210 |
D/D |
108,000 |
1,989,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-27 |
4 |
OE |
$4.42 |
$323,040 |
D/D |
62,000 |
1,943,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-02-03 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,000 |
1,881,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-09 |
4 |
AS |
$100.30 |
$10,843,204 |
D/D |
(108,000) |
1,881,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-27 |
4 |
AS |
$105.85 |
$6,671,080 |
D/D |
(62,000) |
1,881,912 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-07-27 |
4 |
AS |
$106.14 |
$241,150 |
D/D |
(2,272) |
1,879,640 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-10-26 |
4 |
OE |
$2.69 |
$534,197 |
D/D |
99,536 |
1,840,087 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-07-11 |
4 |
S |
$50.00 |
$108,750 |
D/D |
(2,175) |
1,822,372 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-07-27 |
4 |
S |
$57.27 |
$130,862 |
D/D |
(2,285) |
1,820,087 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2011-10-26 |
4 |
AS |
$65.86 |
$5,282,742 |
D/D |
(79,536) |
1,820,087 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-01 |
4 |
OE |
$4.03 |
$72,822 |
D/D |
18,070 |
1,699,904 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
26,468 |
1,699,550 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-11-28 |
4 |
OE |
$4.03 |
$54,465 |
D/D |
13,515 |
1,692,682 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-31 |
4 |
OE |
$4.03 |
$21,419 |
D/D |
5,315 |
1,687,149 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-28 |
4 |
OE |
$4.03 |
$766,305 |
D/D |
125,384 |
1,681,834 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-01 |
4 |
AS |
$115.26 |
$2,082,946 |
D/D |
(18,070) |
1,681,834 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-10-31 |
4 |
AS |
$94.98 |
$758,237 |
D/D |
(7,982) |
1,679,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-27 |
4 |
GD |
$0.00 |
$0 |
D/D |
204,088 |
1,675,552 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-07-31 |
4 |
AS |
$104.96 |
$259,251 |
D/D |
(2,470) |
1,673,082 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-28 |
4 |
AS |
$111.44 |
$8,480,584 |
D/D |
(76,100) |
1,672,114 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-11-28 |
4 |
AS |
$94.96 |
$4,607,334 |
D/D |
(48,515) |
1,644,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-09-27 |
4 |
AS |
$111.96 |
$7,542,011 |
D/D |
(67,000) |
1,632,550 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2012-12-18 |
4 |
AS |
$95.68 |
$3,348,800 |
D/D |
(35,000) |
1,609,167 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-02 |
4 |
AS |
$99.93 |
$779,754 |
D/D |
(7,803) |
1,601,364 |
0 |
- |
|
| ALXN |
Alexion Pharmaceuticals I... |
CEO |
• • – |
2013-01-09 |
4 |
AS |
$99.96 |
$2,718,612 |
D/D |
(27,197) |
1,574,167 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
